Literature DB >> 15122733

The role of the unblinded sponsor statistician.

Steven Snapinn1, Thomas Cook, Deborah Shapiro, Duane Snavely.   

Abstract

In clinical trials sponsored by Merck the unblinded statistician is typically an employee of the company. From a pharmaceutical industry perspective, advantages of this approach include ensuring that the unblinded statistician is knowledgeable regarding the experimental treatments, therapeutic area and study objectives; that the quality of the analysis conforms to rigorous standards; and that the allocation schedule, database and interim results are kept confidential. These advantages are felt to outweigh any potential disadvantages. Copyright 2004 John Wiley & Sons, Ltd.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15122733     DOI: 10.1002/sim.1790

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network.

Authors:  M Chen-Mok; M J VanRaden; E S Higgs; R Dominik
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

Review 2.  A primer on data safety monitoring boards: mission, methods, and controversies.

Authors:  Lisa K Hicks; Andreas Laupacis; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2007-07-28       Impact factor: 17.440

Review 3.  Factors influencing the statistical planning, design, conduct, analysis and reporting of trials in health care: A systematic review.

Authors:  Marina Zaki; Lydia O'Sullivan; Declan Devane; Ricardo Segurado; Eilish McAuliffe
Journal:  Contemp Clin Trials Commun       Date:  2022-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.